US Activist Hedge Fund Institutional SEC 13D 13G — August 03, 2026

03-08-2026

RA Capital Management, L.P. and affiliated entities filed a Schedule 13G with the SEC on August 3, 2026, disclosing beneficial ownership of 3,014,183 shares of Capricor Therapeutics, Inc. common stock, representing a 5.2% stake in the company. The filing is a routine disclosure of a passive investment position, with the reporting persons certifying the shares were not acquired to influence control of the issuer.

• · The filing is made pursuant to Rule 13d-1(c), indicating a passive investment.
• · RA Capital Healthcare Fund, L.P. directly holds the 3,014,183 shares.
• · RA Capital Management, L.P. serves as investment adviser for the Fund and has delegated sole voting and dispositive power over the shares.
• · The Fund disclaims beneficial ownership because it has divested voting and investment power and cannot revoke the delegation on less than 61 days' notice.
• · The percentage ownership is based on 57,911,893 shares outstanding as of May 11, 2026, per the issuer's Form 10-Q filed May 13, 2026.
• · The reporting persons expressly disclaim status as a 'group' for purposes of this Schedule 13G.

03-08-2026

Telemark Asset Management, LLC, Telemark Fund, LP, and Colin S. McNay filed a Schedule 13G on August 3, 2026, disclosing beneficial ownership of 720,000 shares of Andersen Group Inc. Class A Common Stock, representing 5.3% of the 13,472,214 shares outstanding. The filing is a passive investment disclosure under Rule 13d-1(c), with no intent to change or influence control of the issuer.

• · The filing is a Schedule 13G (passive investment disclosure), not a 13D (activist filing).
• · Each Reporting Person disclaims beneficial ownership of securities beyond those actually owned.
• · The filing date is August 3, 2026, with the event date of July 28, 2026.

03-08-2026

Bank of America Corp disclosed a 5.8% beneficial ownership stake in IREN Ltd, holding 21,027,180 ordinary shares as of June 30, 2026. The filing is a routine Schedule 13G by a qualified institutional investor, indicating passive investment intent. No material change in business or strategy is implied.

• · The filing is made under Rule 13d-1(b), confirming passive investment intent.
• · Bank of America Corp holds sole voting power over 21,013,980 shares and sole dispositive power over 21,027,180 shares.
• · The CUSIP corresponds to IREN Limited's ordinary shares under the CINS numbering system.
• · Outstanding share count of 357,378,674 is based on the issuer's Form 10-Q filed May 8, 2026.

03-08-2026

O.Y. Nofar Energy Ltd. and its affiliates increased their stake in Ellomay Capital Ltd. to 75.0% (10,340,946 ordinary shares) through a share exchange on July 29, 2026, acquiring 4,022,000 shares (29.2% of outstanding) from ten Israeli investors in exchange for 1,363,458 newly issued Nofar shares (ratio 0.339:1), with no cash consideration. The acquisition strengthens Nofar's control, having previously acquired 6,318,946 shares in March 2026, and the Reporting Persons intend to continue reviewing their investment, potentially acquiring or disposing of shares. No negative or flat metrics are present; the transaction is purely accretive to ownership.

• · The exchange transaction involved no cash consideration; Nofar issued 1,363,458 new shares.
• · Nofar has undertaken not to conduct a 'Superior Exchange Transaction' for six months from July 29, 2026, unless it adjusts the exchange ratio for current investors.
• · The Reporting Persons may acquire or dispose of additional securities in the future, subject to market conditions.
• · The original acquisition in March 2026 was pursuant to a share purchase agreement dated December 16, 2025, with sellers including S. Nechama Investments, Kanir Joint Investments, and Anat Raphael.
• · The beneficial ownership percentage is based on 13,783,230 outstanding shares as of July 31, 2026.

03-08-2026

3i, LP and affiliated entities filed a Schedule 13D disclosing a 9.9% beneficial ownership stake in Valion Bio, Inc. (formerly Tivic Health Systems, Inc.) as of July 28, 2026. The filing details a series of financing transactions including a $16.3M convertible note, Series B and C preferred stock purchases, and an equity line of credit with Tumim Stone Capital. Notably, on July 29, 2026, 3i, LP demanded the immediate removal of CEO Michael Handley, signaling activist intent.

• · 3i, LP demanded the immediate removal of CEO Michael Handley in a letter dated July 29, 2026.
• · The ELOC Purchase Agreement allows Valion Bio to sell up to $50,000,000 of Common Stock to Tumim Stone at its discretion.
• · Tumim Stone purchased 129,000 shares under the ELOC at an average price of $0.5355 per share and resold 526,770 shares at an average price of $0.7104 per share.
• · The Series B Preferred Stock purchase price was $1,000 per share.
• · The exercise price of warrants issued on June 17, 2026 was adjusted to $0.61628 per share.

03-08-2026

Bank of America Corp filed a Schedule 13G/A with the SEC on August 3, 2026, disclosing a 0.0% beneficial ownership stake in U Power Ltd (UCAR) as of June 30, 2026. The filing indicates Bank of America holds zero Class A Ordinary Shares of U Power, representing no economic or voting interest in the company. This is an amendment to a prior filing, confirming the bank has fully exited its position.

• · The filing is an amendment (13G/A) to a prior Schedule 13G.
• · Bank of America certifies the securities were acquired and held in the ordinary course of business, not to influence control.
• · The CUSIP corresponds to U Power Limited's Class A common stock (CINS).

03-08-2026

Franklin Resources Inc. and its wholly-owned subsidiary BSP Fund HoldCo (Debt Strategy) L.P. disclosed a 46.6% beneficial ownership stake in Franklin BSP Lending Fund, representing 75,000 Class I Shares acquired on January 29, 2026 for $750,000. The filing is an amendment to Schedule 13D, with no recent transactions in the past 60 days and no current plans to acquire or dispose of additional securities.

• · The acquisition was made using HoldCo's own working capital to support the Issuer's investment strategy.
• · Franklin Resources Inc. and the principal shareholders (C. Johnson and R. Johnson Jr.) disclaim beneficial ownership of the Shares and state they are not a group under Rule 13d-5.
• · No transactions in the past 60 days prior to the filing date.
• · The filing includes a joint filing agreement and powers of attorney for Section 13 and 16 reporting obligations.

03-08-2026

Bank of America Corp disclosed a 6.7% beneficial ownership stake in Fulcrum Therapeutics, Inc. as of June 30, 2026, holding 4,468,123 shares of common stock. The filing is a Schedule 13G, indicating passive investment intent, and the stake was acquired in the ordinary course of business.

• · The filing is a Schedule 13G under Rule 13d-1(b), indicating passive investment intent.
• · Bank of America Corp holds the shares through wholly owned subsidiaries including BofA Securities, Inc., Bank of America N.A., and Merrill Lynch International.
• · The beneficial ownership calculation is based on 66,633,321 outstanding shares as reported in the issuer's Form 10-Q dated April 27, 2026.

03-08-2026

Farallon Capital Management, L.L.C. and related entities filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 5,917,400 shares of Agios Pharmaceuticals, Inc. common stock, representing a 9.9% stake as of June 30, 2026. The filing indicates the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · The filing is an amendment to Schedule 13G, filed under Rule 13d-1(b) (passive investment exemption).
• · The shares are held directly by nine Farallon investment partnerships (the 'Farallon Funds').
• · Farallon Capital Management acts as the investment manager for the Farallon Funds.
• · The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not with the purpose of changing or influencing control of Agios Pharmaceuticals.

03-08-2026

Farallon Capital Management, L.L.C. and related entities filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 10,743,063 shares of BridgeBio Pharma, Inc. common stock as of June 30, 2026, representing a 5.5% stake. The filing is a routine passive ownership disclosure under Rule 13d-1(b), indicating the shares were acquired and are held in the ordinary course of business without intent to influence control.

• · The filing is an amendment (13G/A) to a previously filed Schedule 13G, filed on August 3, 2026, with an event date of June 30, 2026.
• · Farallon Capital Management acts as the investment manager for nine investment partnerships (the 'Farallon Funds') that directly hold the shares.
• · The reporting persons include 15 individual managing members/senior managing members of Farallon Capital Management, all of whom share voting and dispositive power over the 10,743,063 shares.
• · The filing certifies that the securities were acquired and are held in the ordinary course of business and not with the purpose of changing or influencing control of BridgeBio Pharma.

03-08-2026

Baillie Gifford & Co disclosed a 6.6% beneficial ownership stake in QXO, Inc. as of June 30, 2026, holding 47,867,886 shares of common stock. The filing was made under Rule 13d-1(b) as an institutional investment adviser, indicating passive investment intent. The stake includes 27,213,875 shares with sole voting power and 47,867,886 shares with sole dispositive power.

• · Baillie Gifford & Co is based in Edinburgh, Scotland, and acts as an investment adviser.
• · The shares are held on behalf of investment advisory clients, including registered investment companies, employee benefit plans, pension funds, and other institutional clients.
• · The filing certifies that the securities were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

03-08-2026

Baillie Gifford & Co filed a Schedule 13G with the SEC on August 3, 2026, reporting beneficial ownership of 2,542,059 ordinary shares of Wix.com Ltd., representing 6.07% of the outstanding shares. The shares are held on behalf of investment advisory clients, and the filing indicates the securities were acquired in the ordinary course of business without intent to influence control.

• · Baillie Gifford & Co holds 1,967,323 shares with sole voting power and 2,542,059 shares with sole dispositive power.
• · The filing is made under Rule 13d-1(b), indicating the filer is an institutional investment adviser.
• · The filing date is August 3, 2026, with the date of change also being August 3, 2026.

03-08-2026

North American Construction Group Ltd. filed a Schedule 13G/A (Amendment No. 2) disclosing that CIBC Global Asset Management Inc. beneficially owned 1,354,606 shares of common stock as of June 30, 2026, representing 4.84% of the outstanding shares. The filing is a routine beneficial ownership disclosure by an institutional investment manager, with no indication of any change in control intent.

• · The filing is an amendment (No. 2) to the initial Schedule 13G.
• · CIBC Global Asset Management Inc. has sole voting and dispositive power over all 1,354,606 shares.
• · The securities were acquired and are held in the ordinary course of business, not for changing or influencing control.
• · The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.

03-08-2026

Baillie Gifford & Co filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 229,930,331 common shares of Nu Holdings Ltd., representing 5.99% of the company's outstanding shares as of June 30, 2026. The filing indicates a decrease from the prior 6.0% ownership level, reflecting a slight reduction in Baillie Gifford's stake. The shares are held on behalf of investment advisory clients, and the filing confirms the position is not intended to influence control of the company.

• · Baillie Gifford & Co holds shares on behalf of investment advisory clients, including investment companies, employee benefit plans, pension funds, and other institutional clients.
• · The filing is made under Rule 13d-1(b) and includes certifications that the shares were not acquired to influence control of the issuer.
• · Baillie Gifford & Co is based in Edinburgh, Scotland, and is a non-U.S. investment adviser.

03-08-2026

Baillie Gifford & Co filed an amended Schedule 13G with the SEC, reporting beneficial ownership of 5,553,823 shares of Service Corp International (SCI) common stock as of June 30, 2026, representing a 4.02% stake. This is a routine disclosure of a passive investment by a major institutional investment adviser, with no change in control intent.

• · Baillie Gifford & Co is an investment adviser organized under the laws of Scotland (non-U.S. entity).
• · The filing is made under Rule 13d-1(b), indicating the securities were acquired in the ordinary course of business and not to influence control.
• · The filing includes a certification that the foreign regulatory scheme applicable to the investment adviser is substantially comparable to the U.S. regulatory scheme.

03-08-2026

Baillie Gifford & Co filed a Schedule 13G with the SEC on August 3, 2026, disclosing beneficial ownership of 49,503,716 ordinary shares of Bending Spoons S.p.A., representing 15.23% of the company's outstanding shares. The shares are held on behalf of investment advisory clients, including registered investment companies, pension funds, and other institutional clients. The filing indicates that Baillie Gifford acquired the shares in the ordinary course of business and not with the intent to influence control of the issuer.

• · Baillie Gifford & Co holds sole voting power over 46,909,983 shares and sole dispositive power over all 49,503,716 shares.
• · The filing is made under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to influence control.
• · The issuer, Bending Spoons S.p.A., is incorporated in Italy (L6) with its business address in Milan, Italy.

03-08-2026

UBS Group AG filed a Schedule 13G/A with the SEC, disclosing beneficial ownership of 2,170,465 common shares of Nuveen California Municipal Value Fund (NCA), representing a 6.6% stake. The filing, dated August 3, 2026, indicates UBS holds the shares in the ordinary course of business and not for the purpose of changing or influencing control of the fund.

• · The filing is an amendment (Schedule 13G/A) to a previous Schedule 13G.
• · UBS Group AG's address is Bahnhofstrasse 45, PO Box CH-8021, Zurich, Switzerland.
• · The filing certifies the securities were acquired in the ordinary course of business and not to influence control.

03-08-2026

TIAA CREF Investment Management LLC filed a Schedule 13G with the SEC on August 3, 2026, disclosing beneficial ownership of 5,313,467 shares of NETSTREIT Corp. common stock, representing 5.46% of the outstanding shares. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · The filing is a Schedule 13G (passive investment, not activist) under Rule 13d-1(b).
• · TCIM directly holds 1,594,383 shares for CREF; NAM holds 1,313,716 shares; TAL holds 2,405,368 shares across multiple funds and accounts.
• · The filing date is August 3, 2026, with the date of event as June 30, 2026.

03-08-2026

Bank of America Corp disclosed a 7.0% beneficial ownership stake in CytomX Therapeutics, Inc., holding 15,134,689 shares as of June 30, 2026. The filing is a routine Schedule 13G, indicating passive investment intent, and the ownership is held through various subsidiaries including BofA Securities and Merrill Lynch.

• · The filing is made under Rule 13d-1(b), confirming passive investment intent.
• · Bank of America Corp is a holding company (HC) with subsidiaries including a bank and broker-dealers.
• · The beneficial ownership calculation is based on 217,702,919 shares outstanding as reported in the issuer's Form 10-Q dated May 7, 2026.

03-08-2026

Bank of America Corp filed a Schedule 13G disclosing beneficial ownership of 857,318 shares of Inhibrx Biosciences, Inc., representing 5.9% of the company's outstanding shares as of June 30, 2026. The filing indicates the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · The beneficial ownership calculation relies on 14,607,286 outstanding shares disclosed in the issuer's Form 8-K on June 3, 2026, with share totals as of April 7, 2026.
• · Bank of America Corp holds the shares through its wholly owned subsidiaries, including BofA Securities, Inc., Bank of America N.A., Merrill Lynch International, Merrill Lynch Pierce Fenner & Smith, Inc., and U.S. Trust Co of Delaware.
• · The filing is made pursuant to Rule 13d-1(b), indicating passive investment intent.

03-08-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC on August 3, 2026, disclosing beneficial ownership of 4,284,274 common shares of CREDICORP LTD (BAP), representing 4.5% of the outstanding shares. The filing is an amendment to a previous 13G and reflects BlackRock's passive investment in the Peruvian financial holding company, with no intent to change or influence control.

• · The filing is an amendment to a previous Schedule 13G, filed pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · BlackRock's beneficial ownership is held through multiple subsidiaries, with BlackRock Fund Managers Ltd noted as beneficially owning 5% or greater of the class.
• · No single person's interest in the common stock exceeds 5% of the total outstanding shares.
• · The filing includes a Power of Attorney dated January 21, 2025, authorizing various individuals to execute ownership reporting documents.

03-08-2026

Maura Brown filed a corrective Schedule 13G with the SEC on August 3, 2026, disclosing beneficial ownership of 146,550 Depositary Receipts (5.3% of the class) in New England Realty Associates Limited Partnership. The filing covers historical ownership dating back to June 30, 2013, when she received 200,000 Depositary Receipts (6.4%) as a gift from her late spouse, Harold Brown. Her ownership has steadily declined from 200,000 units (6.4%) in June 2013 to 146,550 units (5.3%) as of March 31, 2025, reflecting a 26.7% reduction in holdings over the period.

• · The filing was submitted late on a corrective basis to report missed beneficial ownership reports from June 30, 2013 onward.
• · Maura Brown acquired the Depositary Receipts via a gift from her spouse, Harold Brown, on June 30, 2013.
• · Harold Brown, the general partner of the issuer, passed away on February 24, 2019.
• · Maura Brown has sole voting and dispositive power over all 146,550 Depositary Receipts.
• · The filing certifies the securities were not acquired to change or influence control of the issuer.

03-08-2026

Space Summit Capital LLC disclosed beneficial ownership of 1,087,000 Units in East West Ave Acquisition Corp., representing 10.9% of the total Units outstanding, in a Schedule 13G filing dated August 3, 2026. The filing indicates the securities were not acquired for the purpose of changing or influencing control of the issuer.

• · Space Summit Capital LLC is a Delaware limited liability company.
• · The filing was made under Rule 13d-1(c) of the Securities Exchange Act of 1934.
• · The reporting person's business address is 6240 West 3rd Street, #421, Los Angeles, CA 90036.
• · The issuer is a blank check company (SIC 6770) incorporated in Nevada.
• · The filing certifies that the securities were not acquired with the purpose of changing or influencing control of the issuer.

03-08-2026

O-WELL Corp and its wholly-owned subsidiary Uni Electronics Inc. filed a Schedule 13G with the SEC on August 3, 2026, disclosing a combined beneficial ownership of 6.2% of Micware Co., Ltd.'s ordinary shares as of June 30, 2026. O-WELL Corp directly holds 2,224,430 ordinary shares and 80,000 American Depositary Shares (ADSs), while Uni Electronics holds 1,190,540 ordinary shares and 200,053 ADSs. The filing is a routine disclosure of a passive stake exceeding 5% and does not indicate any change in control or active engagement.

• · O-WELL Corp directly holds 2,224,430 ordinary shares and 80,000 ADSs.
• · Uni Electronics Inc. holds 1,190,540 ordinary shares and 200,053 ADSs.
• · The filing is made under Rule 13d-1(d) (passive investor exemption).
• · Both entities are based in Japan; O-WELL Corp in Osaka, Uni Electronics in Tokyo.

03-08-2026

Bank of America Corp filed a Schedule 13G/A with the SEC on August 3, 2026, disclosing beneficial ownership of 19,729 shares of M-tron Industries, Inc. common stock, representing 0.5% of the 4,321,443 outstanding shares. The filing indicates the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (SCHEDULE 13G/A) to a previous Schedule 13G.
• · Bank of America Corp holds 17,594 shares with sole voting power and 19,729 shares with sole dispositive power.
• · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · The beneficial ownership calculation is based on the issuer's Form 10-Q filed on May 13, 2026.

03-08-2026

Boston Partners filed a Schedule 13G/A with the SEC on August 3, 2026, disclosing beneficial ownership of 4,451,621.9 shares of Allegion plc common stock as of June 30, 2026. This represents a 5.18% stake in the company, making Boston Partners a major shareholder. The filing indicates the shares are held for discretionary client accounts and were acquired in the ordinary course of business without intent to influence control.

• · Boston Partners' sole voting power covers 3,714,811 shares, while shared voting power is 0.
• · Boston Partners has sole dispositive power over 4,451,621.9 shares and shared dispositive power over 0 shares.
• · The filing is an amendment (Schedule 13G/A) to a prior Schedule 13G.
• · The securities were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.

03-08-2026

GAMCO Investors, Inc. et al. filed an amended Schedule 13D disclosing aggregate beneficial ownership of 5,054,709 shares (13.44%) of Myers Industries Inc. as of July 31, 2026. The filing details a series of recent sales by Gabelli Funds and GAMCO Asset Management during late July 2026, with prices ranging from $30.59 to $34.55 per share. The filing notes that the Reporting Persons file the long-form Schedule 13D to ensure compliance with Exchange Act reporting obligations despite being eligible for the short form.

• · GAMCO Asset Management Inc. sold a total of 5,060 shares between July 8 and July 31, 2026, at prices from $30.59 to $33.85.
• · Gabelli Funds, LLC (Gabelli Enterprise M&A Fund) sold 12,000 shares between July 28 and July 31, 2026, at prices from $32.75 to $34.55.
• · GAMCO does not have authority to vote 132,100 of the reported shares.
• · The Reporting Persons file the long-form Schedule 13D to ensure compliance with Exchange Act reporting obligations despite being eligible for the short form.

03-08-2026

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. filed a Schedule 13G disclosing a 9.99% beneficial ownership stake in Yarrow Bioscience, Inc. (formerly VYNE Therapeutics Inc.) as of July 27, 2026. The filing indicates the group holds 266,756 shares of common stock, including 266,309 shares directly held by the Master Fund and 447 shares issuable upon exercise of pre-funded warrants subject to a 9.99% beneficial ownership limitation. The filing certifies the securities were not acquired to change or influence control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating it is a passive investment.
• · The pre-funded warrants have an exercise price of $0.0001 per share and are subject to a beneficial ownership limitation of 9.99%.
• · The Reporting Persons certify the securities were not acquired to change or influence control of the issuer.
• · The issuer's principal business address is 470 James Street, Suite 007, New Haven, CT 06513.
• · The filing date is August 3, 2026, with a date of change of July 27, 2026.

03-08-2026

Bank of America Corp filed a Schedule 13G/A with the SEC on August 3, 2026, disclosing beneficial ownership of 2,556,475 shares of MacroGenics Inc (MGNX) common stock, representing 4.0% of the 63,563,123 outstanding shares as of June 30, 2026. The filing is made under Rule 13d-1(b) and certifies the shares were acquired in the ordinary course of business, not for changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a previous Schedule 13G.
• · Bank of America Corp holds no sole voting power over the shares (0 shares), but has shared voting power over all 2,556,475 shares.
• · The filing is made on behalf of Bank of America Corp and its wholly owned subsidiaries including BofA Securities, Inc., Bank of America N.A., Merrill Lynch International, and BofA Securities Europe SA.
• · The beneficial ownership calculation is based on 63,563,123 outstanding shares as reported in the issuer's Form 10-Q dated May 13, 2026 (as of May 8, 2026).

03-08-2026

Alta Partners LLC filed a Schedule 13G/A with the SEC on August 3, 2026, disclosing beneficial ownership of 1,338,133 shares of BioRestorative Therapies, Inc. (BRTX) common stock, representing 4.9% of the outstanding shares. The filing indicates the shares are subject to a 4.99% beneficial ownership limitation contained in the applicable warrant, and the reporting person certifies the securities were not acquired to change or influence control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · Alta Partners LLC is a New York limited liability company.
• · The shares are held directly by Alta Partners LLC with sole voting and dispositive power over all 1,338,133 shares.
• · The beneficial ownership limitation of 4.99% is contained in the applicable warrant, capping the reporting person's ownership.

03-08-2026

Alexander Schornstein filed a Schedule 13G/A with the SEC on August 3, 2026, reporting that he liquidated all of his shares in Lite Strategy, Inc. (formerly MEI Pharma, Inc.) as of June 30, 2026. As a result, he no longer holds any shares and his beneficial ownership has dropped to 0.00% of the company's 34,025,200 outstanding shares. This filing reflects a complete exit by a former major shareholder.

• · Alexander Schornstein's address is Kaiser-Friedrich-Allee 2, 52074 Aachen, Germany.
• · The company's common stock has a par value of $0.00000002 per share.
• · The company's fiscal year ends on June 30.
• · The outstanding share count is based on the company's Form 10-Q filed on May 13, 2026.

03-08-2026

Alta Partners LLC filed a Schedule 13G with the SEC on August 3, 2026, disclosing beneficial ownership of 1,609,686 Class A Ordinary Shares of Elong Power Holding Ltd., representing 9.9% of the outstanding shares. The shares are issuable upon exercise of warrants held by Alta Partners, subject to a 9.99% beneficial ownership limitation. The filing indicates the shares were not acquired for the purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(c) of the Securities Exchange Act of 1934.
• · Alta Partners LLC is a New York limited liability company with its principal business address in Garden City, New York.
• · The beneficial ownership is based on warrants exercisable within 60 days of July 15, 2026.
• · The filing includes a certification that the securities were not acquired to change or influence control of the issuer.

03-08-2026

Bigger Capital Fund, L.P. and related entities filed an amended Schedule 13G/A disclosing beneficial ownership of 180,000 Class A Ordinary Shares of Top Wealth Group Holding Ltd, all of which are issuable upon exercise of warrants (90,000 Series A and 90,000 Series B) subject to a 9.99% beneficial ownership limitation. As of August 3, 2026, the reporting persons' ownership is approximately 0% of the 59,579,883 outstanding Class A Ordinary Shares, well below the 5% threshold, indicating no material stake in the company.

• · The filing is an amendment (SCHEDULE 13G/A) filed on August 3, 2026.
• · The reporting persons disclaim beneficial ownership of shares owned by other reporting persons.
• · The securities were not acquired with the purpose of changing or influencing control of the issuer.
• · The PIPE Transaction closed on July 22, 2026, establishing the share count for percentage calculations.

03-08-2026

Alpha Capital Anstalt filed a Schedule 13G/A with the SEC on August 3, 2026, disclosing beneficial ownership of 5,269,190 shares of AgEagle Aerial Systems Inc. common stock, representing 8.68% of the 60,754,593 shares outstanding as of May 28, 2026. The filing indicates no change in ownership from the prior period, as the same 5,269,190 shares were reported, and Alpha Capital certifies the shares were not acquired to influence control of the issuer.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(c).
• · Alpha Capital Anstalt is based in Vaduz, Liechtenstein.
• · The filer certifies that the securities were not acquired or held to change or influence control of the issuer.

03-08-2026

Coliseum Capital Management and affiliated entities filed a Schedule 13D with the SEC on August 3, 2026, disclosing beneficial ownership of 18,070,762 shares of Sonos Inc. common stock, representing 15.3% of the company. The filing upgrades their previous Schedule 13G, indicating a shift to an activist stance, as they reserve the right to propose changes to Sonos' operations, governance, or capitalization, and may consider extraordinary transactions. The group's total investment cost was approximately $242.2 million, with no transactions in the past 60 days.

• · The Schedule 13D supersedes the previous Schedule 13G (last amended May 15, 2026).
• · Christopher Shackelton is a member of Sonos' board of directors.
• · The reporting persons did not effectuate any transactions in the common stock during the 60 days preceding the filing.
• · The reporting persons may be deemed to be members of a group with respect to the shares owned by CCP and the Separate Account.
• · The reporting persons reserve the right to propose changes to Sonos' operations, governance, or capitalization, and may consider extraordinary transactions such as business combinations or asset sales.
• · The filing was made because the reporting persons may no longer qualify to file on Schedule 13G.

03-08-2026

The filing is a Schedule 13G/A submitted by BlackRock Inc. for Sunstone Hotel Investors, Inc., indicating a passive investment stake. BlackRock reports beneficial ownership of 10,420,000 shares, representing 5.0% of the company's outstanding shares. The filing confirms BlackRock's passive investment intent under Rule 13d-1(b), with no changes in ownership from the previous reporting period, suggesting a stable, long-term holding. However, the filing does not provide any financial metrics, management commentary, or forward-looking guidance for Sunstone Hotel Investors, limiting the depth of analysis.

• · BlackRock Inc. is the reporting institutional investor.
• · The filing is an amendment (13G/A) to a previously filed Schedule 13G.
• · BlackRock's ownership is 10,420,000 shares, unchanged from the prior filing.
• · The ownership percentage is 5.0%, unchanged from the prior filing.
• · BlackRock disclaims beneficial ownership of shares held by certain subsidiaries.
• · The filing confirms BlackRock's passive investment strategy with no intent to influence control.

03-08-2026

Bank of America Corp filed a Schedule 13G/A disclosing beneficial ownership of 742,984 common shares of Array Digital Infrastructure, Inc., representing 1.4% of the 53,437,000 outstanding shares as of June 30, 2026. The filing is a routine passive ownership disclosure under Rule 13d-1(b), indicating the shares were acquired and are held in the ordinary course of business without intent to influence control.

• · Bank of America holds sole voting power over 741,614 shares and sole dispositive power over 742,984 shares.
• · The filing is an amendment (Schedule 13G/A) to a prior Schedule 13G.
• · The ownership percentage is based on 53,437,000 outstanding shares as reported in the issuer's Form 10-Q dated May 8, 2026 (as of March 31, 2026).
• · The filing includes a Power of Attorney (EX-24) authorizing Monica Yako to sign on behalf of Bank of America Corp.

03-08-2026

Bigger Capital Fund LP and related entities filed a Schedule 13G/A disclosing a 5.86% beneficial ownership stake in Neuraxis, INC as of August 3, 2026. Michael Bigger, the managing member of the general partner, is deemed to beneficially own approximately 6.67% of the outstanding common stock, including shares held by his sons and his IRA. The filing also notes that certain warrants are subject to a 4.99% beneficial ownership limitation and are not included in the reported percentages.

• · The filing is an amendment (Schedule 13G/A) filed on August 3, 2026.
• · Bigger Capital Fund LP beneficially owns 731,377 shares (5.86%) but does not include 66,138 warrants exercisable subject to a 4.99% limitation.
• · District 2 Capital Fund LP beneficially owns 94,352 shares (below 5% threshold) and does not include 79,366 warrants subject to a 4.99% limitation.
• · Michael Bigger individually owns 6,000 shares in his IRA and 1,159 shares held by his sons, bringing his total deemed beneficial ownership to 831,729 shares (6.67%).
• · The outstanding share count used for percentage calculations is 12,477,309 shares as of July 22, 2026, per the issuer's Form S-3 filed July 23, 2026.
• · All reporting persons disclaim beneficial ownership of shares owned by other reporting persons.

03-08-2026

Wasatch Advisors LP filed a Schedule 13G/A with the SEC on August 3, 2026, disclosing beneficial ownership of 8,653,092 shares of Paymentus Holdings, Inc. common stock, representing a 13.7% stake. The filing indicates that Wasatch Advisors holds sole voting power over 5,803,302 shares and sole dispositive power over all 8,653,092 shares, with no shared voting or dispositive power. The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

• · Wasatch Advisors LP holds sole dispositive power over all 8,653,092 shares, but sole voting power over only 5,803,302 shares.
• · The filing is an amendment (SC 13G/A) and was made pursuant to Rule 13d-1(b).
• · The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

03-08-2026

Alta Partners LLC filed a Schedule 13G/A with the SEC on August 3, 2026, disclosing beneficial ownership of 1,168,303 shares of C3is Inc. common stock, representing 8.2% of the outstanding shares. The filing indicates that the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · Alta Partners LLC is a New York limited liability company with its principal business address in Old Brookville, NY.
• · The shares were acquired under Rule 13d-1(c), indicating passive investment intent.
• · The filing certifies that the securities were not acquired to change or influence control of the issuer.

03-08-2026

Boston Partners filed a Schedule 13G/A with the SEC on August 3, 2026, disclosing beneficial ownership of 5,185,474 shares of Frontdoor, Inc. common stock as of June 30, 2026, representing a 7.38% stake. The filing indicates that Boston Partners holds these shares for the discretionary accounts of certain clients and certifies that the securities were acquired in the ordinary course of business without the purpose of changing or influencing control of the issuer.

• · Boston Partners has sole voting power over 4,884,314 shares and sole dispositive power over 5,185,474 shares.
• · No person has the right to receive or direct the receipt of dividends or proceeds from the sale of more than 5% of the outstanding shares.
• · The filing is an amendment (SCHEDULE 13G/A) to a previous Schedule 13G.

03-08-2026

Bank of America Corp /DE/ filed a Schedule 13G with the SEC on August 3, 2026, disclosing beneficial ownership of 5,433,645 shares of common stock in Franklin Street Properties Corp /MA/ (FSP), representing a 5.2% stake as of June 30, 2026. The filing is made under Rule 13d-1(b) and includes shares held by wholly owned subsidiaries BofA Securities, Inc., Bank of America N.A., and Merrill Lynch International. The ownership is classified as held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · The Schedule 13G was filed under Rule 13d-1(b), indicating the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
• · Bank of America Corp /DE/ has sole voting power over 0 shares and sole dispositive power over 5,433,645 shares.
• · The filing date is August 3, 2026, with the event date as of June 30, 2026.
• · Franklin Street Properties Corp /MA/ is classified under SIC 6798 (Real Estate Investment Trusts) and is incorporated in Massachusetts.

03-08-2026

UBS Group AG filed an amended Schedule 13G disclosing beneficial ownership of 480,458 shares (30.03%) of the 5.250% Series A Perpetual Preferred Shares of abrdn Income Credit Strategies Fund (ACP-PA) as of June 30, 2026. The filing indicates UBS holds a significant minority stake, but the securities were acquired in the ordinary course of business and not for control purposes. No changes in ownership were reported (0.00 shares bought or sold).

• · The filing is an amendment (13G/A) filed on August 3, 2026, with an effective date of June 30, 2026.
• · UBS Group AG holds the shares through its wholly owned subsidiary UBS Financial Services Inc.
• · The filing is made under Rule 13d-1(b), indicating passive investment intent.
• · No shares were bought or sold during the reporting period (0.00 shares).
• · The fund was formerly known as Aberdeen Income Credit Strategies Fund (name change December 1, 2017).

03-08-2026

Earl Thomas filed a Schedule 13G/A with the SEC on August 3, 2026, reporting beneficial ownership of 22,882,152 shares of Venture Global, Inc. Class A common stock as of June 30, 2026, representing a 4.32% stake. The shares are issuable upon exercise of stock options exercisable within 60 days. No other changes or transactions were disclosed.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · The shares are held of record by the Reporting Person and are issuable upon exercise of stock options exercisable within 60 days of June 30, 2026.
• · The ownership percentage is based on 529,366,047 shares outstanding as reported by the issuer.

03-08-2026

Bank of America Corp disclosed a 6.5% beneficial ownership stake in Research Alliance Corp III, holding 503,914 Class A Ordinary Shares as of June 30, 2026. The filing is a Schedule 13G, indicating passive investment intent, and the stake is held through subsidiaries BofA Securities and Merrill Lynch International.

• · Bank of America holds no derivative securities or short positions.
• · The filing is made under Rule 13d-1(b), confirming passive investment intent.
• · The stake is held on behalf of Bank of America and its wholly owned subsidiaries: BofA Securities, Inc. and Merrill Lynch International.
• · The beneficial ownership calculation uses 7,775,000 outstanding shares as reported in the issuer's Form 10-Q dated July 2, 2026.

03-08-2026

Bank of America Corp. filed a Schedule 13G on August 3, 2026, disclosing a 5.1% beneficial ownership stake in BlackRock Credit Allocation Income Trust (BTZ), representing 4,799,384 common shares as of June 30, 2026. The filing indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer. Bank of America is filing on behalf of itself and its wholly owned subsidiaries, including Bank of America N.A., BofA Securities, Inc., and Merrill Lynch Pierce Fenner & Smith, Inc.

• · The filing was made under Rule 13d-1(b) and is an initial Schedule 13G filing.
• · Bank of America Corp. disclaims sole dispositive power over 4,799,384 shares (zero), but shares dispositive power with other entities (not specified in the extracted data).
• · Bank of America Corp. has sole voting power over only 44,574 shares of BTZ.
• · The filing certifies that the securities were not acquired to change or influence control of the issuer.

03-08-2026

CK Life Sciences Int'l (Holdings) Inc. and its affiliate DEFJ, LLC have increased their beneficial ownership in TransCode Therapeutics to 83.9% following the conversion of all Series A and Series B Preferred Stock into common shares. The conversion, which took place on August 3, 2026, added 13,834,441 shares of common stock, bringing total ownership to 14,134,481 shares. This filing reflects a significant concentration of ownership and the removal of a 60-day notice requirement for waiving beneficial ownership limitations.

• · The Second Amended and Restated Certificate of Designation removed the 60-day notice requirement for waiving beneficial ownership limitations.
• · No additional securities were issued or sold in connection with the filing of the Second Amended and Restated Certificate of Designation.
• · DEFJ converted 21.6755 shares of Series B Preferred Stock into 216,755 shares of Common Stock on July 23, 2026 (the July Conversion).
• · Other than the July Conversion and the August Conversion, the Reporting Persons have not effected any transactions in the Common Stock during the past 60 days.

03-08-2026

RA Capital Management, L.P. and affiliated entities filed a Schedule 13G with the SEC on August 3, 2026, disclosing beneficial ownership of 1,802,178 shares of Scribe Therapeutics, Inc. common stock, representing 9.6% of the 18,864,386 shares outstanding as of July 27, 2026. The filing is a routine passive ownership disclosure under Rule 13d-1(c) and does not indicate any change in control intent.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent with no control purpose.
• · RA Capital Management, L.P. serves as investment adviser for the Fund, Nexus Fund II, and Nexus Fund IV, with delegated sole voting and dispositive power.
• · Each of the Fund, Nexus Fund II, and Nexus Fund IV disclaims beneficial ownership due to delegation of voting and investment power on at least 61 days' notice.
• · Peter Kolchinsky and Rajeev Shah are the controlling persons of RA Capital Management GP, LLC, the general partner of RA Capital Management, L.P.